In a recent interview with PharmaShots, William F. Doyle, Executive Chairman at Novocure shared information about the company’s activities in the field of glioblastoma and mesothelioma. He also discussed the […]readmore
Tags : Novocure
Shots: The companies plan to conduct a P-II pilot study of tumor treating fields concomitant with Keytryda for 1L treatment of intrathoracic advanced/ metastatic PD-L1+ NSCLC. The study will enroll […]readmore
1. Janssen to Present Updated Results of JNJ-4528 in P-Ib/II CARTITUDE-1 Study for Multiple Myeloma at ASCO 2020 Published: May 14, 2020 | Tags: Janssen, Update, Results, JNJ-4528, P-Ib/II, CARTITUDE-1, Study, […]readmore
Shots: The NMPS has approved the combination of MAA for Optune + temozolomide to treat patients with newly diagnosed GBM and a monothx. for patients with recurrent GBM. The P-III […]readmore
Shots: The designation allows Zai Lab to take advantage of an expedited approval procedure for Optune offering opportunities for pre-consultation with an input from the NMPA throughout the approval process […]readmore